– Explore-CKD met its primary endpoint; lorundrostat 25 mg once daily achieved a 9.3 mmHg reduction in systolic blood pressure,…
New York, New York--(Newsfile Corp. - June 17, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company")…
Paris Air Show, Le Bourget – June 16, 2025 – Booth B46 (Alliance NewSpace Pavilion, Paris Space Hub) PARIS, June…
BRUSSELS and AMSTERDAM, June 16, 2025 /PRNewswire/ -- The Innovative Health Initiative (IHI) and Critical Path Institute® (C-Path) today announced…
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to…
RAHWAY, N.J., June 16, 2025 /PRNewswire/ -- Merck Manuals, a comprehensive digital health resource, announced today it has launched a…
Seasoned Executives Join to Support AI-Driven Growth in U.S.-Based Biomanufacturing MADISON, Wis., June 16, 2025 /PRNewswire/ -- Axio BioPharma Inc., a…
First Patients Expected to be Enrolled This MonthHalifax, Nova Scotia--(Newsfile Corp. - June 16, 2025) - Sona Nanotech Inc. (CSE:…
BOSTON and LONDON, June 16, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced…
After a thorough clinical review, the benefit-risk for the use of Elevidys in non-ambulatory patients with Duchenne has been re-assessed,…